AR116663A1 - Compuestos - Google Patents
CompuestosInfo
- Publication number
- AR116663A1 AR116663A1 ARP190101764A ARP190101764A AR116663A1 AR 116663 A1 AR116663 A1 AR 116663A1 AR P190101764 A ARP190101764 A AR P190101764A AR P190101764 A ARP190101764 A AR P190101764A AR 116663 A1 AR116663 A1 AR 116663A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compounds
- hydrogen
- treatment
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108010040201 Polymyxins Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente proporciona un compuesto de polimixina de fórmula (1) y sales, solvatos y formas protegidas del mismo, composiciones farmacéuticas que comprenden los compuestos de fórmula (1), y el uso de los compuestos y composiciones en métodos de tratamiento, tales como métodos para el tratamiento de infecciones microbianas. Los compuestos de fórmula (1) se representan de este modo a continuación, en la que R¹⁵ es un grupo de fórmula (2) y R¹⁶ es hidrógeno; R¹⁷ es hidrógeno; L es un enlace covalente o metileno; y Ar es arilo opcionalmente sustituido. Los grupos X, R¹, R², R³, R⁴, y R⁸ son como se definen en el presente documento.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862689602P | 2018-06-25 | 2018-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR116663A1 true AR116663A1 (es) | 2021-06-02 |
Family
ID=67107423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190101764A AR116663A1 (es) | 2018-06-25 | 2019-06-25 | Compuestos |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US11459357B2 (es) |
| EP (2) | EP4316504A3 (es) |
| JP (2) | JP7488774B2 (es) |
| KR (1) | KR20210054500A (es) |
| CN (2) | CN118878638A (es) |
| AR (1) | AR116663A1 (es) |
| AU (2) | AU2019294261B2 (es) |
| BR (1) | BR112020026663A2 (es) |
| CA (1) | CA3103158A1 (es) |
| CO (1) | CO2020016080A2 (es) |
| DK (1) | DK3810633T3 (es) |
| EA (1) | EA202092819A1 (es) |
| ES (1) | ES2971732T3 (es) |
| FI (1) | FI3810633T3 (es) |
| HR (1) | HRP20240028T1 (es) |
| HU (1) | HUE065134T2 (es) |
| IL (1) | IL279620A (es) |
| LT (1) | LT3810633T (es) |
| MA (1) | MA52946B1 (es) |
| MD (1) | MD3810633T2 (es) |
| MX (1) | MX2020013811A (es) |
| NZ (1) | NZ771833A (es) |
| PH (1) | PH12020552240A1 (es) |
| PL (1) | PL3810633T3 (es) |
| PT (1) | PT3810633T (es) |
| RS (1) | RS65128B1 (es) |
| SG (1) | SG11202012747VA (es) |
| SI (1) | SI3810633T1 (es) |
| TW (1) | TWI851584B (es) |
| UA (1) | UA128162C2 (es) |
| WO (1) | WO2020002325A1 (es) |
| ZA (1) | ZA202301937B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3224273A1 (en) | 2014-11-26 | 2017-10-04 | New Pharma Licence Holdings Limited | Compounds |
| SI3810633T1 (sl) * | 2018-06-25 | 2024-04-30 | Spero Therapeutics, Inc. | Spojine |
| WO2022098950A1 (en) | 2020-11-06 | 2022-05-12 | Spero Therapeutics, Inc. | Compounds |
| WO2022262823A1 (zh) * | 2021-06-18 | 2022-12-22 | 华南理工大学 | 活性氧自由基响应的多粘菌素前药化合物及其应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2128617A (en) | 1982-10-06 | 1984-05-02 | Martti Vaara | Polypeptides for use in antibacterial therapy |
| WO1988000950A2 (en) | 1986-08-06 | 1988-02-11 | Fauchere Jean Luc | Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b |
| US20010021697A1 (en) | 1987-09-14 | 2001-09-13 | Henning Lowenstein | Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| TW274552B (es) | 1992-05-26 | 1996-04-21 | Hoechst Ag | |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| MXPA06003573A (es) | 2003-09-30 | 2006-08-31 | Kohi Corp | Composiciones y metodos para tratar quemaduras. |
| US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| KR20150008198A (ko) | 2006-08-11 | 2015-01-21 | 노던 안티바이오틱스 리미티드 | 폴리믹신 유도체들 및 이들의 용도 |
| US7807637B2 (en) | 2006-08-11 | 2010-10-05 | Northern Antibiotics Oy | Polymyxin derivatives and uses thereof |
| US8193148B2 (en) | 2008-02-08 | 2012-06-05 | Northern Antibiotics Ltd. | Short fatty acid tail polymyxin derivatives and uses thereof |
| US8329645B2 (en) | 2008-02-08 | 2012-12-11 | Northern Antibiotics Ltd. | Polymyxin derivatives and uses thereof |
| FI20085469A0 (fi) | 2008-02-08 | 2008-05-16 | Northern Antibiotics Oy | Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä |
| ES2334547B1 (es) | 2008-09-10 | 2010-12-03 | Universidad De Barcelona | Compuestos peptidicos antibacterianos. |
| WO2010075416A1 (en) | 2008-12-23 | 2010-07-01 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| CN101851270A (zh) | 2009-04-03 | 2010-10-06 | 梁浩 | 一种多粘菌素衍生物及其制备方法 |
| WO2010130007A1 (en) | 2009-05-14 | 2010-11-18 | Monash University | Antimicrobial compounds |
| US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| WO2012051663A1 (en) | 2010-10-21 | 2012-04-26 | Monash University | Antimicrobial compounds |
| WO2012168820A1 (en) * | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| SG11201402390PA (en) | 2011-11-18 | 2014-06-27 | Novacta Biosystems Ltd | Polymyxin derivatives |
| PT2999711T (pt) | 2013-05-22 | 2022-07-29 | Spero Therapeutics Inc | Derivados de polimixina e a sua utilização em terapia de combinação em conjunto com antibióticos diferentes |
| LT3116897T (lt) * | 2014-03-11 | 2022-05-10 | Spero Therapeutics, Inc. | Polimiksino dariniai ir jų panaudojimas kompleksinėje terapijoje kartu su skirtingais antibiotikais |
| AU2015240435B2 (en) | 2014-04-01 | 2019-09-19 | Monash University | Polymyxin derivatives as antimicrobial compounds |
| EP3224273A1 (en) * | 2014-11-26 | 2017-10-04 | New Pharma Licence Holdings Limited | Compounds |
| EP3233906B1 (en) * | 2014-12-17 | 2019-05-01 | F.Hoffmann-La Roche Ag | Enzymatic one-pot reaction for double polypeptide conjugation in a single step using sortase |
| WO2016166103A1 (en) * | 2015-04-13 | 2016-10-20 | Xellia Pharmaceuticals Aps | Polymyxin derivatives |
| AU2016331658B2 (en) * | 2015-09-29 | 2021-04-01 | Monash University | Antimicrobial polymyxin derivative compounds |
| WO2017218867A1 (en) * | 2016-06-16 | 2017-12-21 | Aeras | Tuberculosis compositions and methods of treating or preventing tuberculosis |
| SI3810633T1 (sl) * | 2018-06-25 | 2024-04-30 | Spero Therapeutics, Inc. | Spojine |
| WO2020014501A1 (en) | 2018-07-11 | 2020-01-16 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of bacterial infections |
-
2019
- 2019-06-25 SI SI201930707T patent/SI3810633T1/sl unknown
- 2019-06-25 PT PT197343460T patent/PT3810633T/pt unknown
- 2019-06-25 DK DK19734346.0T patent/DK3810633T3/da active
- 2019-06-25 HU HUE19734346A patent/HUE065134T2/hu unknown
- 2019-06-25 UA UAA202008220A patent/UA128162C2/uk unknown
- 2019-06-25 FI FIEP19734346.0T patent/FI3810633T3/fi active
- 2019-06-25 CN CN202410703525.5A patent/CN118878638A/zh active Pending
- 2019-06-25 JP JP2020571762A patent/JP7488774B2/ja active Active
- 2019-06-25 CN CN201980041706.3A patent/CN112789287B/zh active Active
- 2019-06-25 PL PL19734346.0T patent/PL3810633T3/pl unknown
- 2019-06-25 MX MX2020013811A patent/MX2020013811A/es unknown
- 2019-06-25 RS RS20240128A patent/RS65128B1/sr unknown
- 2019-06-25 EP EP23215457.5A patent/EP4316504A3/en active Pending
- 2019-06-25 US US17/253,426 patent/US11459357B2/en active Active
- 2019-06-25 EP EP19734346.0A patent/EP3810633B1/en active Active
- 2019-06-25 SG SG11202012747VA patent/SG11202012747VA/en unknown
- 2019-06-25 TW TW108122117A patent/TWI851584B/zh active
- 2019-06-25 NZ NZ771833A patent/NZ771833A/en unknown
- 2019-06-25 MD MDE20210390T patent/MD3810633T2/ro unknown
- 2019-06-25 BR BR112020026663-9A patent/BR112020026663A2/pt unknown
- 2019-06-25 WO PCT/EP2019/066819 patent/WO2020002325A1/en active Application Filing
- 2019-06-25 HR HRP20240028TT patent/HRP20240028T1/hr unknown
- 2019-06-25 AR ARP190101764A patent/AR116663A1/es unknown
- 2019-06-25 LT LTEPPCT/EP2019/066819T patent/LT3810633T/lt unknown
- 2019-06-25 MA MA52946A patent/MA52946B1/fr unknown
- 2019-06-25 AU AU2019294261A patent/AU2019294261B2/en active Active
- 2019-06-25 EA EA202092819A patent/EA202092819A1/ru unknown
- 2019-06-25 ES ES19734346T patent/ES2971732T3/es active Active
- 2019-06-25 CA CA3103158A patent/CA3103158A1/en active Pending
- 2019-06-25 KR KR1020217000402A patent/KR20210054500A/ko unknown
-
2020
- 2020-12-21 PH PH12020552240A patent/PH12020552240A1/en unknown
- 2020-12-21 IL IL279620A patent/IL279620A/en unknown
- 2020-12-22 CO CONC2020/0016080A patent/CO2020016080A2/es unknown
-
2022
- 2022-08-23 US US17/893,944 patent/US20230012121A1/en active Pending
-
2023
- 2023-02-06 ZA ZA2023/01937A patent/ZA202301937B/en unknown
-
2024
- 2024-05-10 JP JP2024077064A patent/JP2024109664A/ja active Pending
- 2024-05-21 AU AU2024203362A patent/AU2024203362A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR116663A1 (es) | Compuestos | |
| AR123048A2 (es) | Moduladores de p2x7 | |
| ECSP15029636A (es) | Nuevos compuestos bicíclicos y su uso como agentes antibacterianos e inhibidores de beta-lactamasa | |
| CL2019002032A1 (es) | Procesos para preparar un inhibidor de jak1 (divisional de solicitud 1790-2018). | |
| CO2017009891A2 (es) | Inhibidores de inhibidores del factor beta de crecimiento de transformación (tgf-beta) | |
| UY37310A (es) | Compuestos de indol sustituidos con [1,2,4]triazolo[1,5-a]piridinilo | |
| CL2018000666A1 (es) | Nuevos compuestos de espiro[3h-indol-3,2´-pirrolidin]-2(1h)-ona y derivados como inhibidores de mdm2-p53. | |
| UY35898A (es) | ?compuestos inhibidores de syk y composiciones que los comprenden?. | |
| CO2017000223A2 (es) | Compuestos antiproliferativos y métodos de uso de los mismos | |
| BR112015023397A2 (pt) | benzoxazois substituídos e métodos de uso dos mesmos | |
| UY35617A (es) | Inhibidores de la fosfatidilinositol 3-quinasa | |
| BR112015022488A2 (pt) | triazolopiridinas substituídas e métodos de uso das mesmas | |
| UY36285A (es) | Compuestos que inhiben la proteína mcl-1 | |
| ECSP14020586A (es) | Composición para el control de plagas que incluye un derivado de iminopiridina novedoso | |
| MX2013006847A (es) | Compuesto heterociclico fusionado y su uso para el control de plagas. | |
| AR095426A1 (es) | Inhibidores tripeptídicos de la epoxicetona proteasa | |
| AR098776A1 (es) | Derivados del isocromeno como inhibidores de las fosfoinositido-3 quinasas | |
| AR084553A1 (es) | DERIVADOS IMIDAZOLICOS HETEROCICLICOS INHIBIDORES DE b-SECRETASA, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y USO DE LOS MISMOS PARA TRATAR ENFERMEDADES NEURODEGENERATIVAS, EN PARTICULAR ALZHEIMER | |
| MX2013008868A (es) | Nuevas azaindolifenil sulfonamidas como inhibidores de serina/treonina cinasa. | |
| UY35242A (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| BR112019007108A2 (pt) | misturas herbicidas | |
| BR112016029846A2 (pt) | ?composto, composição farmacêutica, métodos para o método para tratamento de um humano, para inibição da atividade de um polipeptídio de fosfatidilinositol 3-quinase e inibição excessiva ou reações imunes destrutivas ou crescimento ou uma proliferação de células de câncer, kit, e, uso de um composto, um sal farmaceuticamente aceitável, isômero, ou uma mistura do mesmo? | |
| DOP2019000140A (es) | Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih | |
| DOP2010000022A (es) | Derivados de pirimidina 934 | |
| BR112015013485A2 (pt) | derivados de benzilsulfonamida como moduladores de rorc |